HCM
PMN icon

Heights Capital Management’s ProMIS Neurosciences PMN Stock Holding History

Heights Capital Management’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$643K Buy
+50,660
New +$755K 0.18% 107
2025
Q2 		– Sell
-731
Closed -$12.9K – 179
2025
Q1 		$12.9K Sell
731
-5,677
-89% -$121K 0.01% 91
2024
Q4 		$152K Sell
6,408
-9,068
-59% -$226K 0.08% 63
2024
Q3 		$484K Buy
+15,476
New +$578K 0.36% 37

Other funds holding PMN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM

Heights Capital Management's PMN Position: Q1 2026 in Review

Heights Capital Management opened a new position in ProMIS Neurosciences (PMN) in Q1 2026: 50,660 shares worth $643K. The stake represents 0.18% of the portfolio and ranks #107 among its holdings. This is a return to the name: Heights Capital Management previously reported a position in PMN as recently as Q1 2025.

Heights Capital Management first reported a position in PMN in Q3 2024 and has held it in 4 quarters since. 25 funds tracked by Wall St. Rank hold PMN as of Q1 2026.

  • Heights Capital Management held 50,660 shares of ProMIS Neurosciences worth $643K as of Q1 2026.
  • ProMIS Neurosciences was a new Heights Capital Management position in Q1 2026.
  • ProMIS Neurosciences made up 0.18% of Heights Capital Management's portfolio in Q1 2026, its #107 holding.
  • Heights Capital Management first reported a position in ProMIS Neurosciences in Q3 2024 and has held it in 4 quarters since.
  • 25 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q1 2026.

Based on Heights Capital Management's 13F filing for Q1 2026, filed 15 May 2026.